The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Whole‐Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis
Open accessAbstract
Objective: Macrophage activation syndrome (MAS), a life‐threatening complication of systemic juvenile idiopathic arthritis (JIA), resembles familial hemophagocytic lymphohistiocytosis (HLH), a constellation of autosomal‐recessive immune disorders resulting from deficiency in cytolytic pathway proteins. We undertook this study to test our hypothesis that MAS predisposition in systemic JIA could be attributed to rare gene sequence variants affecting the cytotolytic pathway. Methods: Whole‐exome sequencing was used in 14 patients with systemic JIA and MAS and in their parents to identify protein‐altering single‐nucleotide polymorphisms/indels in known HLH‐associated genes. To discover new candidate genes, the entire whole‐exome sequencing data were filtered to identify protein‐altering, rare recessive homozygous, compound heterozygous, and de novo variants with the potential to affect the cytolytic pathway. Results: Heterozygous protein‐altering rare variants in the known genes (LYST,MUNC13‐4, and STXBP2) were found in 5 of 14 patients with systemic JIA and MAS (35.7%). This was in contrast to only 4 variants in 4 of 29 patients with systemic JIA without MAS (13.8%). Homozygosity and compound heterozygosity analysis applied to the entire whole‐exome sequencing data in systemic JIA/MAS revealed 3 recessive pairs in 3 genes and compound heterozygotes in 73 genes. We also identified 20 heterozygous rare protein‐altering variants that occurred in at least 2 patients. Many of the identified genes encoded proteins with a role in actin and microtubule reorganization and vesicle‐mediated transport. “Cellular assembly and organization” was the top cellular function category based on Ingenuity Pathways Analysis (P < 3.10 × 10−5). Conclusion: Whole‐exome sequencing performed in patients with systemic JIA and MAS identified rare protein‐altering variants in known HLH‐associated genes as well as in new candidate genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In patients with secondary HLH, viral, autoimmune, or neoplastic disorders trigger cytokine storm, and such patients often have heterozygous polymorphisms in the same genes that are altered in primary HLH.65,74”
From Cytokine storm (2020) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Henter, J., Horne, A., Aricò, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., Ladisch, S., McClain, K. L., Webb, D. K. H., Winiarski, J. H., et al. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.21039 · Cited by 5,396
Self-citationDe novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
Ravelli, A., & Martini, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60363-8 · Cited by 2,017
Exome sequencing identifies the cause of a mendelian disorder
Ng, S. B., Buckingham, K. J., Lee, C., Bigham, A. W., Tabor, H. K., Dent, K. M., Huff, C. D., Shannon, P. T., Jabs, E. W., Nickerson, D. A., et al. (2010) · Nature Genetics · doi:10.1038/ng.499 · Cited by 1,957
ARF proteins: roles in membrane traffic and beyond
D’Souza‐Schorey, C., & Chavrier, P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1910 · Cited by 1,362
Perforin Gene Defects in Familial Hemophagocytic Lymphohistiocytosis
Stepp, S. E., Dufourcq-Lagelouse, R., Deist, F. L., Bhawan, S., Dogniaux, S., Mathew, P. A., Henter, J., Bennett, M., Fischer, A., Basile, G. D. S., et al. (1999) · Science · doi:10.1126/science.286.5446.1957 · Cited by 1,236
Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban 1997
Petty, R. E., Southwood, T. R. E., Baum, J., Bhettay, E., Glass, D. N., Manners, P. J., Maldonado-Cocco, J. A., Suarez-Almazor, M. E., Orozco-Alcalá, J., & Prieur, A. (2001) · CRC Press eBooks · doi:10.3109/9780203214237-62 · Cited by 1,175
Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome
Ménasché, G., Pastural, É., Feldmann, J., Dogniaux, S., Ersoy, F., Dupuis, S., Wulffraat, N. M., Bianchi, D. W., Fischer, A., Deist, F. L., et al. (2000) · Nature Genetics · doi:10.1038/76024 · Cited by 957
Flagged first, then by citations
Cited by
Sorted by citations
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196
Ravelli, A., Minoia, F., Davì, S., Horne, A., Bovis, F., Pistorio, A., Aricò, M., Avčin, T., Behrens, E. M., Benedetti, F. D., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39332 · Cited by 770
Self-citationThe Immunology of Macrophage Activation Syndrome
Crayne, C. B., Albeituni, S., Nichols, K. E., & Cron, R. Q. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00119 · Cited by 633
Interleukin‐18: Biological properties and role in disease pathogenesis
Kaplanski, G. (2017) · Immunological Reviews · doi:10.1111/imr.12616 · Cited by 621
Pediatric hemophagocytic lymphohistiocytosis
Canna, S., & Marsh, R. A. (2020) · Blood · doi:10.1182/blood.2019000936 · Cited by 504
Macrophage activation syndrome in the era of biologic therapy
Grom, A. A., Horne, A., & Benedetti, F. D. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.179 · Cited by 450
Self-citationJordan, M. B., Allen, C. E., Greenberg, J., Henry, M., Hermiston, M. L., Kumar, A. R., Hines, M., Eckstein, O. S., Ladisch, S., Nichols, K. E., et al. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27929 · Cited by 428
Ravelli, A., Minoia, F., Davì, S., Horne, A., Bovis, F., Pistorio, A., Aricò, M., Avčin, T., Behrens, E. M., Benedetti, F. D., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208982 · Cited by 409
Self-citationPathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies
Schulert, G. S., & Grom, A. A. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-061813-012806 · Cited by 401
Self-citationWeiss, E. S., Girard-Guyonvarc’h, C., Holzinger, D., de Jesus, A. A., Tariq, Z., Picarsic, J. L., Schiffrin, E. J., Foell, D., Grom, A. A., Ammann, S., et al. (2018) · Blood · doi:10.1182/blood-2017-12-820852 · Cited by 406
Self-citationHemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy
Griffin, G., Shenoi, S., & Hughes, G. C. (2020) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2020.101515 · Cited by 352
Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era
Behrens, E. M., & Koretzky, G. A. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40071 · Cited by 307
Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis
Karakike, E., & Giamarellos‐Bourboulis, E. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00055 · Cited by 304
Bracaglia, C., de Graaf, K., Marafon, D. P., Guilhot, F., Ferlin, W. G., Prencipe, G., Caiello, I., Davì, S., Schulert, G. S., Ravelli, A., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-209020 · Cited by 290
Self-citationBenefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
Eloseily, E. M., Weiser, P., Crayne, C. B., Haines, H., Mannion, M. L., Stoll, M. L., Beukelman, T., Atkinson, T. P., & Cron, R. Q. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41103 · Cited by 282
Cifaldi, L., Prencipe, G., Caiello, I., Bracaglia, C., Locatelli, F., Benedetti, F. D., & Strippoli, R. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39295 · Cited by 267
Emergent high fatality lung disease in systemic juvenile arthritis
Saper, V. E., Chen, G., Deutsch, G. H., Guillerman, R. P., Birgmeier, J. A., Jagadeesh, K. A., Canna, S., Schulert, G. S., Deterding, R. R., Xu, J., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216040 · Cited by 228
Self-citationMacrophage Activation Syndrome
Ravelli, A., Davì, S., Minoia, F., Martini, A., & Cron, R. Q. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.06.010 · Cited by 211
Cetica, V., Sieni, E., Pende, D., Danesino, C., Fusco, C. D., Locatelli, F., Micalizzi, C., Putti, M. C., Biondi, A., Fagioli, F., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.06.048 · Cited by 209
Cytokine storm syndrome in coronavirus disease 2019: A narrative review
Gao, Y.-M., Xu, G., Wang, B., & Liu, B. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13144 · Cited by 204
Biological and clinical roles of IL-18 in inflammatory diseases
Landy, E., Carol, H. A., Ring, A. M., & Canna, S. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-01053-w · Cited by 218
Brisse, E., Wouters, C. H., & Matthys, P. (2016) · British Journal of Haematology · doi:10.1111/bjh.14147 · Cited by 197
Schulert, G. S., Zhang, M., Fall, N., Husami, A., Kissell, D., Hanosh, A., Zhang, K., Davis, K., Jentzen, J. M., Napolitano, L., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv550 · Cited by 170
Self-citationSystemic Juvenile Idiopathic Arthritis
Lee, J. J. Y., & Schneider, R. (2018) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2018.04.005 · Cited by 175
Henderson, L. A., & Cron, R. Q. (2019) · Pediatric Drugs · doi:10.1007/s40272-019-00367-1 · Cited by 168
Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis
Allen, C. E., & McClain, K. L. (2015) · Hematology · doi:10.1182/asheducation-2015.1.177 · Cited by 164
Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndrome
Bracaglia, C., Prencipe, G., & Benedetti, F. D. (2017) · Pediatric Rheumatology · doi:10.1186/s12969-016-0130-4 · Cited by 160
Macrophage activation syndrome: early diagnosis is key
Lerkvaleekul, B., & Vilaiyuk, S. (2018) · Open Access Rheumatology Research and Reviews · doi:10.2147/oarrr.s151013 · Cited by 151
Grom, A. A., Ilowite, N. T., Pascual, V., Brunner, H. I., Martini, A., Lovell, D. J., Ruperto, N., Leon, K., Lheritier, K., & Abrams, K. B. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39407 · Cited by 129
Self-citationPrencipe, G., Caiello, I., Pascarella, A., Grom, A. A., Bracaglia, C., Chatel, L., Ferlin, W. G., Marasco, E., Strippoli, R., de Min, C., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.021 · Cited by 120
Self-citationImmune cartography of macrophage activation syndrome in the COVID-19 era
McGonagle, D., Ramanan, A. V., & Bridgewood, C. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00571-1 · Cited by 120
Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome
Carcillo, J. A., Podd, B. S., Aneja, R. K., Weiss, S. L., Hall, M. W., Cornell, T. T., Shanley, T. P., Doughty, L., & Nguyen, T. C. (2017) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000001052 · Cited by 110
Halyabar, O., Chang, M. H., Schoettler, M. L., Schwartz, M. A., Barış, H. E., Benson, L. A., Biggs, C. M., Gorman, M., Lehmann, L., Lo, M. S., et al. (2019) · Pediatric Rheumatology · doi:10.1186/s12969-019-0309-6 · Cited by 108
Wu, Y., Sun, X., Kang, K., Yang, Y., Li, H., Zhao, A., & Niu, T. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01621-x · Cited by 115
An Overview of Hemophagocytic Lymphohistiocytosis
Esteban, Y., de Jong, J. L. O., & Tesher, M. S. (2017) · Pediatric Annals · doi:10.3928/19382359-20170717-01 · Cited by 98
Approaching hemophagocytic lymphohistiocytosis
Chinnici, A., Beneforti, L., Pegoraro, F., Trambusti, I., Tondo, A., Favre, C., Coniglio, M. L., & Sieni, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1210041 · Cited by 99
Morris, G., Bortolasci, C. C., Puri, B. K., Marx, W., O'Neil, A. E., Athan, E., Walder, K. R., Berk, M., OLIVE, L. S., Carvalho, A. F., et al. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155593 · Cited by 101
Boom, V., Antón, J., Lahdenne, P., Quartier, P., Ravelli, A., Wulffraat, N. M., & Vastert, S. J. (2015) · Pediatric Rheumatology · doi:10.1186/s12969-015-0055-3 · Cited by 95
Carvelli, J., Pipéroglou, C., Farnarier, C., Vely, F., Mazodier, K., Audonnet, S., Nitschké, P., Bôle‐Feysot, C., Boucékine, M., Cambon, A., et al. (2020) · Blood · doi:10.1182/blood.2019003664 · Cited by 94
The genetics of macrophage activation syndrome
Schulert, G. S., & Cron, R. Q. (2020) · Genes & Immunity · doi:10.1038/s41435-020-0098-4 · Cited by 91
Li, X., Shao, M., Zeng, X., Qian, P., & Huang, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00764-4 · Cited by 94
Adult-Onset Still’s Disease: Clinical Aspects and Therapeutic Approach
Tomaras, S., Goetzke, C. C., Kallinich, T., & Feist, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040733 · Cited by 84
COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?
Ombrello, M. J., & Schulert, G. S. (2021) · Translational research · doi:10.1016/j.trsl.2021.03.002 · Cited by 84
Convergent pathways of the hyperferritinemic syndromes
Schulert, G. S., & Canna, S. (2018) · International Immunology · doi:10.1093/intimm/dxy012 · Cited by 77
Highways to hell: Mechanism-based management of cytokine storm syndromes
Canna, S., & Cron, R. Q. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.09.016 · Cited by 74
From bench to bedside and back again: translational research in autoinflammation
Holzinger, D., Kessel, C., Omenetti, A., & Gattorno, M. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.79 · Cited by 69
Yasin, S., & Schulert, G. S. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000526 · Cited by 69
Pardeo, M., Bracaglia, C., & De Benedetti, F. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2018.02.002 · Cited by 60
Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg
Crayne, C. B., & Cron, R. Q. (2019) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2019.19150 · Cited by 67
Minoia, F., Bovis, F., Davì, S., Insalaco, A., Lehmberg, K., Shenoi, S., Weitzman, S. S., Espada, G., Gao, Y., Antón, J., et al. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.06.005 · Cited by 65
Self-citationVandenhaute, J., Wouters, C. H., & Matthys, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03089 · Cited by 66
Leiding, J. W., & Forbes, L. R. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.12.017 · Cited by 56
Familial Hemophagocytic Lymphohistiocytosis
Degar, B. A. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.06.008 · Cited by 55
Schulert, G. S., Zhang, M., Husami, A., Fall, N., Brunner, H. I., Zhang, K., Cron, R. Q., & Grom, A. A. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40438 · Cited by 51
Self-citationNew monogenic autoinflammatory diseases—a clinical overview
Canna, S., & Goldbach‐Mansky, R. T. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0493-5 · Cited by 50
Han, S. B., & Lee, S. Y. (2020) · World Journal of Pediatrics · doi:10.1007/s12519-020-00360-6 · Cited by 47
Carcillo, J. A., Simon, D. W., & Podd, B. S. (2015) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000460 · Cited by 45
Adults with septic shock and extreme hyperferritinemia exhibit pathogenic immune variation
Kernan, K. F., Ghaloul‐Gonzalez, L., Shakoory, B., Kellum, J. A., Angus, D. C., & Carcillo, J. A. (2018) · Genes and Immunity · doi:10.1038/s41435-018-0030-3 · Cited by 45
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis
Erkens, R. G. A., Esteban, Y., Towe, C. T., Schulert, G. S., & Vastert, S. J. (2021) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2021.06.003 · Cited by 45
Hemophagocytic Lymphohistiocytosis
Skinner, J., Yankey, B., & Shelton, B. K. (2019) · AACN Advanced Critical Care · doi:10.4037/aacnacc2019463 · Cited by 45
Ruscitti, P., Cipriani, P., Benedetto, P. D., Liakouli, V., Carubbi, F., Berardicurti, O., Ciccia, F., Guggino, G., Triolo, G., & Giacomelli, R. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1372194 · Cited by 44
Schulert, G. S., Pickering, A., Do, T., Dhakal, S., Fall, N., Schnell, D., Medvedovic, M., Salomonis, N., Thornton, S., & Grom, A. A. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217470 · Cited by 44
Self-citationVerweyen, E. L., & Schulert, G. S. (2021) · Lara D. Veeken · doi:10.1093/rheumatology/keab673 · Cited by 43
The link between rheumatic disorders and inborn errors of immunity
Sogkas, G., & Witte, T. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104501 · Cited by 42
Sandborg, C. I., Schulert, G. S., & Kimura, Y. (2025) · New England Journal of Medicine · doi:10.1056/nejmra2402073 · Cited by 40
mTORC1 links pathology in experimental models of Still’s disease and macrophage activation syndrome
Huang, Z., You, X., Chen, L., Du, Y., Brodeur, K. E., Jee, H., Wang, Q., Linder, G., Darbousset, R., Cunin, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34480-6 · Cited by 39
Yıldız, H., Bailly, S., Neste, E. V. D., & Yombi, J. C. (2021) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s195538 · Cited by 38
Macrophage Activation Syndrome
Ravelli, A., Minoia, F., Davì, S., & Martini, A. (2016) · Technical report · doi:10.1016/b978-0-444-63596-9.00004-9 · Cited by 38
Interleukin-18 in pediatric rheumatic diseases
Prencipe, G., Bracaglia, C., & Benedetti, F. D. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000634 · Cited by 35
Macrophage activation syndrome in systemic juvenile idiopathic arthritis
Shimizu, M. (2021) · Immunological Medicine · doi:10.1080/25785826.2021.1912893 · Cited by 35
Chellapandian, D., Hines, M., Zhang, R., Jeng, M., van den Bos, C., López, V. S., Lehmberg, K., Sieni, E., Wang, Y., Nakano, T. A., et al. (2018) · Cancer · doi:10.1002/cncr.31893 · Cited by 34
The critical impacts of cytokine storms in respiratory disorders
Tramboo, S. R., Elkhalifa, A. M. E., Khursheed, S. Q., Ali, S. I., Shah, N. N., Taifa, S., Rakhshan, R., Shah, I. H., Mir, M. A., Malik, M., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29769 · Cited by 32
Rocco, J. M., Laidlaw, E., Galindo, F., Anderson, M. V., Rupert, A. W., Higgins, J. M., Sortino, O., Ortega‐Villa, A. M., Sheikh, V., Roby, G. A., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac717 · Cited by 33
Future Biomarkers for Infection and Inflammation in Febrile Children
Zandstra, J., Jongerius, I., & Kuijpers, T. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631308 · Cited by 34
Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations
Woerner, A., von Scheven-Gête, A., Cimaz, R., & Hofer, M. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1032257 · Cited by 32
Heterogeneity of macrophage activation syndrome and treatment progression
Dong, Y., Wang, T., & Wu, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1389710 · Cited by 31
The Multifaceted Immunology of Cytokine Storm Syndrome
Lee, P. Y., & Cron, R. Q. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200808 · Cited by 33
Takakura, M., Shimizu, M., Irabu, H., Sakumura, N., Inoue, N., Mizuta, M., Nakagishi, Y., & Yachie, A. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.108252 · Cited by 30
Digenic Inheritance: Evidence and Gaps in Hemophagocytic Lymphohistiocytosis
Steen, E. A., Hermiston, M. L., Nichols, K. E., & Meyer, L. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.777851 · Cited by 30
Systemic Juvenile Idiopathic Arthritis
Benedetti, F. D., & Schneider, R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24145-8.00016-8 · Cited by 29
Inflammasomes and Childhood Autoimmune Diseases: A Review of Current Knowledge
Yang, C., & Chiang, B. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08825-2 · Cited by 27
Shen, T. S., Lee, A., Shen, C., & Lin, C. J. (2015) · Genetics Research · doi:10.1017/s0016672315000166 · Cited by 27
Hemophagocytic lymphohistiocytosis: an update for nephrologists
Filippone, E. J., & Farber, J. L. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1294-z · Cited by 27
Schulert, G. S., Bove, K. E., McMasters, R. L., Campbell, K. M., Leslie, N., & Grom, A. A. (2014) · Arthritis Care & Research · doi:10.1002/acr.22527 · Cited by 26
Self-citationMa, Y., Chen, X., Wang, M., Meng, J., Zhu, D., Chen, L., Xiao, Y., Yi, D., Shi, H., Liu, H., et al. (2025) · Blood · doi:10.1182/blood.2024024362 · Cited by 25
Diagnosis, Treatment, and Management of Hemophagocytic Lymphohistiocytosis in the Critical Care Unit
Hines, M., Bhatt, N. S., & Talano, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-01322-6_9 · Cited by 25
Ahmari, A. A., Alsmadi, O. A., Sheereen, A., Elamin, T., Jabr, A., El-Baik, L., Alhissi, S., Al‐Saud, B., Al-Awwami, M. A., Fawaz, I. A., et al. (2021) · Blood Research · doi:10.5045/br.2021.2020308 · Cited by 25
Diagnosis and Treatment of Systemic Juvenile Idiopathic Arthritis
Shenoi, S., & Wallace, C. A. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.06.056 · Cited by 24
Macrophage Activation Syndrome in Children: Update on Diagnosis and Treatment
Lee, J. Y., Bae, K. S., Rhim, J. W., Lee, S. Y., Jeong, D. C., & Kang, J. H. (2024) · Children · doi:10.3390/children11070755 · Cited by 23
Barut, K., Yucel, G., Sinoplu, A. B., Şahin, S., Adroviç, A., & Kasapçopur, Ö. (2015) · Türk Pediatri Arşivi · doi:10.5152/turkpediatriars.2015.3299 · Cited by 23
COVID-19-associated secondary hemophagocytic lymphohistiocytosis (cytokine storm syndrome)
Alexeeva, E. I., Фаридович, Т. Р., Shilkrot, I. Y., Dvoryakovskaya, T. M., Surkov, A. G., & Kriulin, I. A. (2021) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn1410 · Cited by 29
Kostik, M. M., Isupova, E. A., Belozerov, K. E., Likhacheva, T. S., Suspitsin, E. N., Raupov, R. K., Masalova, V. V., Чикова, И. А., Dubko, M. F., Kalashnikova, O. V., et al. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.894846 · Cited by 22
Harnchoowong, S., Soponkanaporn, S., Vilaiyuk, S., Lerkvaleekul, B., & Pakakasama, S. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.941318 · Cited by 22
Hemophagocytic lymphohistiocytosis as an etiology of bone marrow failure
Paolino, J. D., Berliner, N., & Degar, B. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1016318 · Cited by 24
Shimizu, M., Mizuta, M., Yasumi, T., Iwata, N., Okura, Y., Kinjo, N., Umebayashi, H., Kubota, T., Nakagishi, Y., Nishimura, K., et al. (2017) · Arthritis Care & Research · doi:10.1002/acr.23482 · Cited by 22
Dilemmas in diagnosis and management of hemophagocytic lymphohistiocytosis in children
Xu, X., & Tang, Y. (2019) · World Journal of Pediatrics · doi:10.1007/s12519-019-00299-3 · Cited by 20
Pang, D., Bashir, D. A., Carcillo, J. A., Nguyen, T. C., Aneja, R. K., & Alcamo, A. M. (2018) · Journal of Pediatric Intensive Care · doi:10.1055/s-0038-1675639 · Cited by 18
Weal and woe of interleukin-18 in the T cell therapy of cancer
Kessel, C., Rössig, C., & Abken, H. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010545 · Cited by 17
Put, K., Brisse, E., Avau, A., Imbrechts, M., Mitera, T., Janssens, R., Proost, P., Fallarino, F., Wouters, C. H., & Matthys, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150075 · Cited by 17
Haploinsufficiency of UNC13D increases the risk of lymphoma
Löfstedt, A., Ahlm, C., Tesi, B., Bergdahl, I. A., Nordenskjöld, M., Bryceson, Y. T., Henter, J., & Meeths, M. (2019) · Cancer · doi:10.1002/cncr.32011 · Cited by 17
Metadata
- Authors
- Kaufman, K. M., Linghu, B., Szustakowski, J. D., Husami, A., Yang, F., Zhang, K., Filipovich, A. H., Fall, N., Harley, J. B., Nirmala, N. R., & Grom, A. A.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Novartis Institutes for BioMedical Research Cambridge Massachusetts
- ORCID
- Venue
- Arthritis & Rheumatology
- Publisher
- Wiley
- Published
- 2014-11-25
- Volume
- 66
- Issue
- 12
- Pages
- 3486-3495
- ISSN
- 2326-5191 (ISSN-L)
- 2326-5205
- PMC
- PMC4321811
- OpenAlex
- W1908769349
- Cited by
- 207
- References
- 51
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 23 · 2023: 12 · 2022: 14 · 2021: 21 · 2020: 17 · 2019: 32 · 2018: 12 · 2017: 14 · 2016: 17 · 2015: 21 · 2014: 2
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Arthritis & Rheumatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- The Novartis Repository (Novartis) (submittedVersion)
- Funders
- National Institutes of Health (RO1-AR059049)
- Topics
- Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- macrophage activation syndrome, systemic juvenile idiopathic arthritis, familial hemophagocytic lymphohistiocytosis, rare variants, compound heterozygosity, homozygosity, de novo mutations, LYST, Munc13-4, STXBP2, vesicle trafficking, candidate genes
- MeSH terms
- Adolescent, Arthritis, Juvenile, Child, Child, Preschool, Female, Genotype, Humans, Infant, Male, Mutation, Parents, Sequence Analysis, DNA, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Lymphohistiocytosis, Hemophagocytic, Macrophage Activation Syndrome, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
